Fatty acid composition of plasma lipids in patients with pancreatic, lung and oesophageal cancer in comparison with healthy subjects.

BACKGROUND & AIMS Despite the general notion of impaired nutritional status in cancer patients, studies on fatty acid status in cancer patients are limited. The aim of the present study was to investigate whether plasma n-3 fatty acids concentrations are reduced in patients with different tumour types. METHODS We measured fatty acid composition in plasma phospholipids (PLs) and cholesteryl esters (CEs) in 71 newly diagnosed, untreated cancer patients of three tumour types: oesophageal or cardia cancer (n = 35), non-small cell lung cancer (n = 22) and pancreatic cancer (n = 15) and in 45 healthy subjects. RESULTS In pancreatic cancer, plasma n-3 fatty acids showed a substantial reduction in both plasma PLs and CES. Although n-3 fatty acids in lung cancer also tended to be reduced, this difference failed to reach statistical significance. n-3 Fatty acid levels were especially reduced in pancreatic cancer patients without diabetes mellitus, and in lung cancer patients with weight loss. In oesophageal cancer, n-3 fatty acid concentrations were comparable to those in healthy subjects. CONCLUSION We conclude that plasma n-3 fatty acid levels were reduced in pancreatic cancer, tended to be reduced in lung cancer, but were not altered in oesophageal cancer. Further studies are needed to assess the mechanisms underlying the observed changes in n-3 fatty acid concentrations.

[1]  P. Dagnelie,et al.  Incorporation and washout of orally administered n-3 fatty acid ethyl esters in different plasma lipid fractions , 1999, British Journal of Nutrition.

[2]  K. Fearon,et al.  Fish oil-enriched nutritional supplement attenuates progression of the acute-phase response in weight-losing patients with advanced pancreatic cancer. , 1999, The Journal of nutrition.

[3]  D. McMillan,et al.  Pancreatic Cancer as a Model: Inflammatory Mediators, Acute-phase Response, and Cancer Cachexia , 1999, World Journal of Surgery.

[4]  D. Horrobin,et al.  Essential fatty acid status in cell membranes and plasma of patients with primary Sjogren's syndrome. Correlations to clinical and immunologic variables using a new model for classification and assessment of disease manifestations. , 1998, Prostaglandins, leukotrienes, and essential fatty acids.

[5]  Á. Gil,et al.  Abnormalities in plasma and red blood cell fatty acid profiles of patients with colorectal cancer. , 1998, British Journal of Cancer.

[6]  J. Ross,et al.  Proinflammatory cytokines, nutritional support, and the cachexia syndrome , 1998, Cancer.

[7]  C. Gogos,et al.  Dietary omega‐3 polyunsaturated fatty acids plus vitamin E restore immunodeficiency and prolong survival for severely ill patients with generalized malignancy , 1998, Cancer.

[8]  D. Talwar,et al.  Effect of inflammation on measures of antioxidant status in patients with non-small cell lung cancer. , 1997, The American journal of clinical nutrition.

[9]  V. Nachiappan,et al.  Ethanol-mediated promotion of oesophageal carcinogenesis: association with lipid peroxidation and changes in phospholipid fatty acid profile of the target tissue. , 1997, Alcohol and alcoholism.

[10]  P. Mortensen,et al.  Essential fatty acid deficiency in patients with severe fat malabsorption. , 1997, The American journal of clinical nutrition.

[11]  J. Lacki,et al.  Prognostic value of serial serum interleukin-6 level estimation in patients with lung cancer: a preliminary report. , 1997, The Yale journal of biology and medicine.

[12]  W. Browner,et al.  Relation of smoking and alcohol consumption to serum fatty acids. , 1996, American journal of epidemiology.

[13]  M. Katan,et al.  Modulation of inflammation and cytokine production by dietary (n-3) fatty acids. , 1996, The Journal of nutrition.

[14]  D. S. Lin,et al.  Differential mobilization of fatty acids from adipose tissue. , 1996, Journal of lipid research.

[15]  R. Abbate,et al.  Platelet activation and platelet lipid composition in pulmonary cancer. , 1995, Prostaglandins, leukotrienes, and essential fatty acids.

[16]  N. Pellegrini,et al.  Evaluation of the effect of alcohol consumption on erythrocyte lipids and vitamins in a healthy population. , 1995, Alcoholism, clinical and experimental research.

[17]  S. Cunnane,et al.  Moderate, selective depletion of linoleate and alpha-linolenate in weight-cycled rats. , 1995, The American journal of physiology.

[18]  J. Ross,et al.  Cytokines, the Acute‐Phase Response, and Resting Energy Expenditure in Cachectic Patients with Pancreatic Cancer , 1994, Annals of surgery.

[19]  S. Cockayne,et al.  Clinical Chemistry: Concepts and Applications , 1993 .

[20]  E. Cabré,et al.  Plasma polyunsaturated fatty acid pattern in active inflammatory bowel disease. , 1992, Gut.

[21]  U. Das,et al.  Reactive oxygen species, lipid peroxides and essential fatty acids in patients with rheumatoid arthritis and systemic lupus erythematosus. , 1991, Prostaglandins, leukotrienes, and essential fatty acids.

[22]  M. Manku,et al.  Abnormalities of essential fatty acid distribution in the plasma phospholipids of patients with bladder cancer. , 1991, British Journal of Cancer.

[23]  C. Mosconi,et al.  Decrease of polyunsaturated fatty acids and elevation of the oleic/stearic acid ratio in plasma and red blood cell lipids of malnourished cancer patients. , 1989, JPEN. Journal of parenteral and enteral nutrition.

[24]  B. Levin,et al.  Cancer of the esophagus , 1987 .

[25]  H. Makin,et al.  A rapid and simple method for the esterification of fatty acids and steroid carboxylic acids prior to gas-liquid chromatography. , 1981, Clinica chimica acta; international journal of clinical chemistry.

[26]  K. Hellsing,et al.  Manual immunoephelometric assay of proteins, with use of polymer enhancement. , 1974, Clinical chemistry.

[27]  J. Folch,et al.  A simple method for the isolation and purification of total lipides from animal tissues. , 1957, The Journal of biological chemistry.

[28]  K. Fearon,et al.  Relationship of serum levels of interleukin-6, soluble interleukin-6 receptor and tumour necrosis factor receptors to the acute-phase protein response in advanced pancreatic cancer. , 1999, Clinical science.

[29]  P. Calder,et al.  n-3 polyunsaturated fatty acids and cytokine production in health and disease. , 1997, Annals of nutrition & metabolism.

[30]  K. Fearon,et al.  The effect of polyunsaturated fatty acids on the progress of cachexia in patients with pancreatic cancer. , 1996, Nutrition.

[31]  Z. Zadák,et al.  [Essential fatty acids in carcinoma]. , 1991, Vnitrni lekarstvi.

[32]  G. Walldius,et al.  Fatty acid composition in serum lipids and adipose tissue in severe obesity before and after six weeks of weight loss. , 1989, International journal of obesity.

[33]  N. Tietz.  Clinical guide to laboratory tests , 1983 .